P4HA2诱导慢性胆汁淤积性肝病中的胆管反应和胆汁性纤维化
该研究在原发性胆汁性胆管炎(PBC)和原发性硬化性胆管炎(PSC)患者及P4HA2基因敲除小鼠中探索P4HA2的作用。发现P4HA2在PBC/PSC患者肝内高表达且与肝损伤严重程度相关,P4HA2缺失可减轻DDC诱导的胆管反应和纤维化,机制涉及SAV1降解及YAP磷酸化调控。
要点
- PBC和PSC患者肝内P4HA2表达显著升高,胆管反应性胆管细胞主要表达P4HA2。
- P4HA2敲除小鼠在DDC诱导的慢性胆汁淤积中胆管反应和纤维化水平显著降低。
- P4HA2通过诱导SAV1降解激活YAP,促进胆管细胞增殖。
核心结论
- P4HA2通过调控SAV1介导的Hippo信号通路促进肝内胆管反应和胆汁性纤维化,是PBC和PSC的潜在治疗靶点。
研究设计与样本
- 研究纳入PBC和PSC患者及对照,采用免疫组化和免疫荧光检测P4HA2。
- 使用DDC损伤的P4HA2-/-小鼠和P4HA2-/-/MDR2-/-双敲除小鼠模型,通过组织学、qPCR、免疫组化和Western blot监测胆管反应和胆汁性纤维化。
- 在分离的小鼠胆管细胞中检测YAP磷酸化,并在RBE和293T细胞系中通过qPCR、Western blot、免疫荧光和共免疫沉淀探索机制。
主要发现
- PBC或PSC患者肝内P4HA2表达水平高度升高,胆管反应性胆管细胞主要表达P4HA2。
- 肝损伤更严重的胆汁淤积患者与肝内P4HA2水平相关。
- 与对照组相比,P4HA2-/-小鼠在DDC诱导的慢性胆汁淤积中胆管反应和纤维化水平显著降低。
- 与MDR2-/-小鼠相比,P4HA2-/-/MDR2-/-小鼠肝纤维化和胆管反应减少。
- 从P4HA2-/-/MDR2-/-小鼠分离的胆管细胞显示YAP磷酸化水平升高,导致胆管细胞增殖受抑制。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: Prolyl-4-hydroxylases (P4Hs) are key enzymes in collagen synthesis. The P4HA subunit (P4HA1, P4HA2, and P4HA3) contains a substrate binding and catalyzation domain. We postulated that P4HA2 would play a key role in the cholangiocyte pathology of cholestatic liver diseases. METHODS: We studied humans with primary biliary cholangitis (PBC) and Primary sclerosing cholangitis (PSC), P4HA2 -/- mice injured by DDC, and P4HA2 -/- /MDR2 -/- double knockout mice. A parallel study was performed in patients with PBC, PSC, and controls using immunohistochemistry and immunofluorescence. In the murine model, the level of ductular reaction and biliary fibrosis were monitored by histology, qPCR, immunohistochemistry, and Western blotting. Expression of Yes1 Associated Transcriptional Regulator (YAP) phosphorylation was measured in isolated mouse cholangiocytes. The mechanism of P4HA2 was explored in RBE and 293T cell lines by using qPCR, Western blot, immunofluorescence, and co-immunoprecipitation. RESULTS: The hepatic expression level of P4HA2 was highly elevated in patients with PBC or PSC. Ductular reactive cholangiocytes predominantly expressed P4HA2. Cholestatic patients with more severe liver injury correlated with levels of P4HA2 in the liver. In P4HA2 -/- mice, there was a significantly reduced level of ductular reaction and fibrosis compared with controls in the DDC-induced chronic cholestasis. Decreased liver fibrosis and ductular reaction were observed in P4HA2 -/- /MDR2 -/- mice compared with MDR2 -/- mice. Cholangiocytes isolated from P4HA2 -/- /MDR2 -/- mice displayed a higher level of YAP phosphorylation, resulting in cholangiocytes proliferation inhibition. In vitro studies showed that P4HA2 promotes RBE cell proliferation by inducing SAV1 degradation, eventually resulting in the activation of YAP. CONCLUSIONS: P4HA2 promotes hepatic ductular reaction and biliary fibrosis by regulating the SAV1-mediated Hippo signaling pathway. P4HA2 is a potential therapeutic target for PBC and PSC.
引用
- Zhang J, Lyu Z, Li B, et al. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. Hepatology. 2023. PMID: 36799463. doi:10.1097/HEP.0000000000000317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。